Spain · Delayed Price · Currency is EUR BME:REN Statistics
Total Valuation
BME:REN has a market cap or net worth of EUR 29.43 million. The enterprise value is 25.40 million.
| Market Cap | 29.43M |
| Enterprise Value | 25.40M |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:REN has 32.47 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 32.47M |
| Shares Outstanding | 32.47M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.78% |
| Owned by Institutions (%) | 10.41% |
| Float | 18.32M |
Valuation Ratios
The trailing PE ratio is 11.71.
| PE Ratio | 11.71 |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | 1.97 |
| P/OCF Ratio | 1.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.51, with an EV/FCF ratio of 1.70.
| EV / Earnings | 10.12 |
| EV / Sales | 0.56 |
| EV / EBITDA | 4.51 |
| EV / EBIT | 4.92 |
| EV / FCF | 1.70 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.85 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | 0.30 |
| Interest Coverage | 2.92 |
Financial Efficiency
Return on equity (ROE) is 3.85% and return on invested capital (ROIC) is 5.48%.
| Return on Equity (ROE) | 3.85% |
| Return on Assets (ROA) | 2.72% |
| Return on Invested Capital (ROIC) | 5.48% |
| Return on Capital Employed (ROCE) | 6.04% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | 1.16M |
| Profits Per Employee | 64,359 |
| Employee Count | 39 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, BME:REN has paid 513,000 in taxes.
| Income Tax | 513,000 |
| Effective Tax Rate | 16.97% |
Stock Price Statistics
The stock price has increased by +29.41% in the last 52 weeks. The beta is 0.63, so BME:REN's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +29.41% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 72.85 |
| Average Volume (20 Days) | 33,611 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:REN had revenue of EUR 45.38 million and earned 2.51 million in profits. Earnings per share was 0.08.
| Revenue | 45.38M |
| Gross Profit | 13.59M |
| Operating Income | 3.89M |
| Pretax Income | 3.02M |
| Net Income | 2.51M |
| EBITDA | 4.16M |
| EBIT | 3.89M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 8.51 million in cash and 4.48 million in debt, with a net cash position of 4.03 million or 0.12 per share.
| Cash & Cash Equivalents | 8.51M |
| Total Debt | 4.48M |
| Net Cash | 4.03M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 62.93M |
| Book Value Per Share | 1.94 |
| Working Capital | 14.51M |
Cash Flow
In the last 12 months, operating cash flow was 15.00 million and capital expenditures -35,000, giving a free cash flow of 14.96 million.
| Operating Cash Flow | 15.00M |
| Capital Expenditures | -35,000 |
| Depreciation & Amortization | 268,000 |
| Net Borrowing | -16.36M |
| Free Cash Flow | 14.96M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 29.94%, with operating and profit margins of 8.57% and 5.53%.
| Gross Margin | 29.94% |
| Operating Margin | 8.57% |
| Pretax Margin | 6.66% |
| Profit Margin | 5.53% |
| EBITDA Margin | 9.16% |
| EBIT Margin | 8.57% |
| FCF Margin | 32.97% |
Dividends & Yields
BME:REN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | 8.53% |
| FCF Yield | 50.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:REN has an Altman Z-Score of 1.12 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.12 |
| Piotroski F-Score | 7 |